(HealthDay)—The prevalence of amyotrophic lateral sclerosis (ALS) was 5.0 per 100,000 persons in 2014, which was unchanged from 2013, according to research published in the Feb. 23 issue of the U.S. Centers for Disease ...
Feb 26, 2018
0
9
When the protein Ataxin1 accumulates in neurons it causes a neurological condition called spinocerebellar ataxia type 1 (SCA1), a disease characterized by progressive problems with balance. Ataxin1 accumulates because of ...
Feb 22, 2018
0
5
Low muscle strength during the later teen years has been identified as a risk factor for much later onset of the neurological disease known as ALS, or amyotrophic lateral sclerosis. A study at Sahlgrenska Academy published ...
Feb 2, 2018
0
1
Researchers at Western University have uncovered a unique neurobiological pathway triggered by head trauma which underlies both Chronic Traumatic Encephalopathy (CTE) and Lou Gehrig's disease.
Jan 16, 2018
0
12
Scientists have revealed more details of the molecular mechanism behind neuronal cell death in amyotrophic lateral sclerosis (ALS), a step toward controlling progression of the disease.
Dec 27, 2017
0
5
University of Michigan-led research brings scientists one step closer to understanding the development of neurodegenerative disorders such as ALS.
Dec 8, 2017
0
1
Researchers at the University of Arizona have taken an essential step forward in the quest to find the cause of amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. In the cells of flies, mice and humans ...
Dec 5, 2017
0
2
It is estimated that between 14,000 and 15,000 Americans have amyotrophic lateral sclerosis (ALS), according to the National Institutes of Health. Symptoms of ALS, also known as Lou Gehrig's disease, may be subtle at first ...
Dec 4, 2017
0
18
Our brains function by electrical and chemical signalling. Recording brain wave patterns can be very helpful in conditions like epilepsy, but the potential of this inexpensive and easily applied technology has not been fully ...
Nov 28, 2017
0
2
Researchers from the University of Montréal Hospital Research Centre (CRCHUM) and the Cumming School of Medicine (CSM) at the University of Calgary have discovered a medication that could make it possible to treat individuals ...
Nov 16, 2017
0
0
